@misc{indiciae0934e5295073,
  title = {Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant},
  author = {Rosales, R. and McGovern, B. L. and Rodriquez, M. L. and Rai, D. K. and Cardin, R. D. and Anderson, A. S. and Sordillo, E. M. and van Bakel, H. and Simon, V. and Garcia-Sastre, A. and White, K. M.},
  year = {2022},
  doi = {10.1101/2022.01.17.476685},
  url = {https://www.biorxiv.org/content/10.1101/2022.01.17.476685v1},
  note = {Source identifier: 10.1101/2022.01.17.476685}
}